Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
bioMerieux (DE:EYWN)
FRANKFURT:EYWN
bioMerieux (EYWN) Stock Price & Analysis
3 Followers
EYWN Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€84.92 - €106.20
Previous Close€102
Volume0.00
Average Volume (3M)20.00
Market Cap
€11.82B
Enterprise Value€11.81B
Total Cash (Recent Filing)€552.60M
Total Debt (Recent Filing)€505.40M
Price to Earnings (P/E)N/A
Beta0.73
Next Earnings
Sep 04, 2024EPS EstimateN/A
Next Dividend Ex-Date
Jun 07, 2024Dividend Yield0.85%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume20
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€115.04Price Target Upside12.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
EYWN FAQ
What was bioMerieux’s price range in the past 12 months?
bioMerieux lowest stock price was €84.92 and its highest was €106.20 in the past 12 months.
What is bioMerieux’s market cap?
Currently, no data Available
When is bioMerieux’s upcoming earnings report date?
bioMerieux’s upcoming earnings report date is Sep 04, 2024 which is in 122 days.
How were bioMerieux’s earnings last quarter?
bioMerieux released its earnings results on Mar 14, 2024. The company reported €1.659 earnings per share for the quarter, beating the consensus estimate of N/A by €1.659.
Is bioMerieux overvalued?
According to Wall Street analysts bioMerieux’s price is currently Undervalued.
Does bioMerieux pay dividends?
bioMerieux pays a Annually dividend of €0.85 which represents an annual dividend yield of 0.85%. See more information on bioMerieux dividends here
What is bioMerieux’s EPS estimate?
bioMerieux’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does bioMerieux have?
Currently, no data Available
What happened to bioMerieux’s price movement after its last earnings report?
bioMerieux reported an EPS of €1.659 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.218%.
Which hedge fund is a major shareholder of bioMerieux?
Currently, no hedge funds are holding shares in DE:EYWN
---
bioMerieux Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
9.72%
Trailing 12-Months
Asset Growth
1.40%
Trailing 12-Months
Company Description
bioMerieux
BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (about 38% of sales), microbiology (about 32%), immunoassays (about 15%), and industrial applications (about 15%). Europe, the Middle East, and Africa accounts for the largest portion of the firm's revenue (38%), followed by North America (38%), Asia-Pacific (17%), and Latin America (7%). BioMerieux is headquartered in Marcy-l'Etoile, France.
---
EYWN Stock 12 Months Forecast
Average Price Target
€115.04
▲(12.78% Upside)
Technical Analysis
Best Analysts Covering EYWN
1 Year
1 Year Success Rate
6/7 ratings generated profit
1 Year Average Return
+4.49%
reiterated a buy rating 2 months ago
Copying Robert Davies's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +4.49% per trade.
---